𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytoplasmic domain of the β-amyloid protein precursor of Alzheimer's disease: Function, regulation of proteolysis, and implications for drug development

✍ Scribed by Megan L. Kerr; David H. Small

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
200 KB
Volume
80
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis

The ␤-amyloid protein precursor (APP) has been extensively studied for its role in amyloid production and the pathogenesis of Alzheimer's disease (AD). However, little is known about the normal function of APP and its biological interactions. In this Mini-Review, the role of the cytoplasmic domain of APP in APP trafficking and proteolysis is described. These studies suggest that proteins that bind to the cytoplasmic domain may be important targets for drug development in AD.

📜 SIMILAR VOLUMES

Role of amyloid β peptides in the regula
Role of amyloid β peptides in the regulation of central cholinergic function and its relevance to Alzheimer's disease pathology
✍ S. Kar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

## Abstract The neuropathological features associated with Alzheimer's disease (AD) brain include the presence of extracellular neuritic plaques composed of amyloid β protein (Aβ), intracellular neurofibrillary tangles containing hyperphosphorylated tau protein, and the loss of basal forebrain chol

Interaction between Alzheimer's disease
Interaction between Alzheimer's disease βA4 precursor protein (APP) and the extracellular matrix: Evidence for the participation of heparan sulfate proteoglycans
✍ Jorge Cáceres; Enrique Brandan 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB 👁 1 views

The interaction between the Alzheimer amyloid precursor protein (APP) and an intact extracellular matrix (ECM), matrigel, obtained from Engelbreth-Holm-Swarm tumors was evaluated. Based on quantitative analyses of the binding data obtained from solid phase binding assays, two binding sites on the EC

The diagnostic value of tau protein, β-a
The diagnostic value of tau protein, β-amyloid (1–42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages
✍ Elisabeth Kapaki; Ioannis Liappas; George P. Paraskevas; Ilia Theotoka; Andreas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Background Chronic and heavy alcohol abuse or dependence may result in impaired cognition and dementia. The increased risk of Alzheimer's disease (AD) in older individuals interferes with the differential diagnosis, especially when dealing with elderly patients with a long history of alcohol abuse.